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Background: In north-western Spain, piroplamosis caused by Theileria annae is now recognized as a serious problem
because veterinarians, despite being aware of the clinical signs of piroplasmosis, lack the necessary information on its
epidemiology or specific diagnostic tools for its management. This, along with the fact that T. annae infection is also
refractory to current piroplamosis treatments, prompted this study designed to assess the clinical presentation and
diagnosis of this largely unknown parasitic disease in dogs.
Methods: One hundred and twenty dogs in NW Spain suspected clinically of having piroplasmosis were examined and
piroplasm species detected by light microscopy (LM) observation of Giemsa-stained blood smears, immunofluorescent
antibody test (IFAT), and PCR plus sequencing.
Results: Seventy five of the sick dogs were confirmed to be infected with T. annae by PCR (designated “true infection
cases”). Intraerythrocytic ring-shaped bodies morphologically compatible with small piroplasms were observed by LM
in 59 (57 true infections) of the 120 blood samples. Anti-Babesia antibodies were detected by IFAT in 59 of the 120 sera
(55 of which were “true infections”). Using PCR as the reference method, moderate agreement was observed between
positive LM vs PCR and IFAT vs PCR results (kappa values: 0.6680 and 0.6017, respectively). Microscopy examination and
IFAT were moderately sensitive in detecting the pathogen (76% and 73.3%, respectively). In the 75 cases of “true
infection”, the most common clinical signs observed were pale mucous membranes, anorexia and apathy. Blood cell
counts consistently revealed severe regenerative anaemia and thrombocytopenia in dogs with piroplasmosis due to T.
annae. Young dogs (≤3 year) (p = 0.0001) were more susceptible to the disease.
Conclusion: Microscopy showed moderate diagnostic sensitivity for acute T. annae infection while IFAT-determined
antibody titres were low (1/64 to 1/128). The infecting species should be therefore confirmed by molecular tests. Our
results suggest that the disease affects dogs in regions of Spain bordering the endemic Galicia area where this
piroplasm has not been previously reported (Asturias, northern Spain). Further epidemiological surveys based on
serological and molecular methods are required to establish the current geographical range of T. annae infection.
Keywords: Theileria annae, Babesia microti-like, Canine piroplasmosis, Tick-borne diseases, Dog, IFAT, PCR* Correspondence: gmiro@ucm.es
1Department of Animal Health, Veterinary Faculty, Universidad Complutense
de Madrid, Madrid, Spain
Full list of author information is available at the end of the article
© 2015 Miró et al.; licensee BioMed Central. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Miró et al. Parasites & Vectors  (2015) 8:217 Page 2 of 11Background
Theileria annae (syn. Babesia microti-like) is a recently
recognized piroplasm that causes canine piroplasmosis
along with other species of the genera Theileria and
Babesia [1,2].
Historically, Babesia infection in dogs was identified
according to the morphologic appearance of the parasite
in the erythrocyte. Based on relative size, these parasites
are broadly divided into two groups, large and small
piroplasms. Although all large forms reported to date
have been ascribed to the genus Babesia, small Babesia
spp. and Theileria spp. cannot be distinguished by
microscopy and DNA-based molecular techniques are
required for an accurate identification [3,4]. Indeed, it is
currently unclear if the protozoan T. annae is a member
of the genus Theileria or Babesia [2,5]. No evidence was
initially presented [2] for extra-erythrocytic infecting
stages or for the absence of transovarial transmission in
ticks (distinguishing features of Theileria spp.). Morpho-
logically, T. annae resembles small piroplasms such as
Babesia gibsoni which, phylogenetically, is considered a
“true babesia”. Molecularly, however, it appears to be
closer to the genetically-distinct rodent piroplasm B.
microti (B. microti group) and only distantly related to
“true theilerias” such as Theileria parva [2,6,7].
At present, 12 piroplasm species have been reported
in dogs worldwide but some of these have been only de-
tected by molecular techniques [1]. Four species have
been described in Europe: Babesia canis, Babesia vogeli,
B. gibsoni and T. annae.
Babesia canis is endemic in temperate regions and is
the most common species reported in Europe (northern
Spain, Portugal, France, central Europe and Eastern
Europe). Babesia vogeli and B. gibsoni are widely distrib-
uted across both Old and New World continents [8,9]. In
Europe, B. vogeli has been described in the Mediterranean
basin, whereas B. gibsoni only occasionally appears in
Europe [10], mainly as the consequence of introduced in-
fected dogs from endemic areas (Asia, United States and
Australia) [8].
Studies in the United States and Australia have indi-
cated that direct dog to dog transmission (in American
Pit bull terriers and other fighting dogs) is likely and this
could be the main mode of transmission outside Asia for
B. gibsoni [11,12].
T. annae was first described in 2000 in a dog from
Germany that had travelled to the Pyrenees [2]. Today,
the infection is considered endemic in NW Spain
(Galicia) [5,13]. Using molecular techniques T. annae
has been also detected in Spanish regions outside Galicia,
such as Barcelona [14], and in other countries including
NW Portugal [15], Croatia [16], US [12] and Sweden [17].
However, in most cases the travel history of the dogs was
unknown. Other authors have reported cases of T. annaeinfecting foxes in Spain [18], Portugal [19], Italy [20],
Croatia [21], Canada [22] and the US [23]. Among all piro-
plasm species reported in Europe, T. annae seems to show
the greatest preference for foxes. Thus, T. annae has been
detected in red foxes in Spain and Portugal at prevalences
from 14% to 69.2%, respectively; while B. canis has been
only occasionally identified in these animals [19]. To date,
there are no available data regarding clinical impacts on
foxes.
The transmission vector of T. annae is presently un-
known. Ixodes hexagonus has been proposed as a likely
candidate because endemic areas of T. annae infection
closely match its distribution range [18,24]. However, T.
annae DNA has been observed in both I. hexagonus and
I. ricinus, though no data exist to substantiate their com-
petence as vectors for T. annae.
T. annae-infected dogs show severe clinical signs and
clinicopathological abnormalities resembling those of
other piroplasm infections such as fever, pale mucous
membranes or haemoglobinuria [25]. Despite morpho-
logic differences, T. annae is often ascribed by veterinar-
ians to other Babesia spp. mainly B. canis. Currently,
there are no diagnostic tools to distinguish between the
different piroplasms in routine veterinary practice and
their detection by microscopy in red blood cells is still
the only method available to practitioners. In laboratory
settings, the immunofluorescent antibody test (IFAT) is
the most widely used test for a serology diagnosis and is
considered highly sensitive and moderately specific to
detect chronic infection and subclinical infection in
carriers [4,26,27]. The polymerase chain reaction (PCR)
is a sensitive and specific diagnostic test widely
employed to diagnose canine babesiosis. When PCR is
combined with sequencing, species-specific primers/
probes, or restriction fragment length polymorphism
(RFLP) analysis it can be used to detect infected dogs
with low parasitaemia levels and to identify parasites
[12,28,29]. However, the literature lacks widespread
serological and/or molecular surveys of T. annae infec-
tion. Similarly, comparative methodological studies on
the available diagnostic procedures are limited.
The present study was designed to examine the clin-
ical picture of T. annae infection in dogs in NW Spain
and assess how best to diagnose this largely unknown
disease.
Methods
Sample and data collection
Over the period June 2012 to January 2014, dogs from
several Veterinary Clinics in NW Spain were tested for
Theileria annae. Inclusion criteria for the enrolment of
dogs were clinical signs suggestive of piroplasmosis such as:
pale mucous membranes, apathy, anorexia, orangey faeces,
fever, weight loss, or haematuria. In all dogs the presence of
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via microscopy by collaborating practitioners.
All participating dogs were subjected to a clinical exam-
ination and blood collection. From each dog, a 4.5 ml
blood sample was obtained by cephalic venipuncture and
1.5 ml of the collected blood placed in two EDTA tubes: a
1 ml tube used for full blood counts and blood smears;
and a 0.5 ml tube used to detect T. annae by genomic
DNA isolation, PCR and sequencing. Also, 3 ml of the
collected blood samples were placed in tubes without anti-
coagulant for biochemical profiles and antibody testing.
All blood samples were kept at 4°C until processing.
In the clinical file, we recorded the: identification
number, age, breed, sex, weight, rural or urban living en-
vironment and travel history. Also considered were the
clinical history and the specific clinical signs at the time
of sampling such as changes in the colour of mucous
membranes, anorexia, haematuria, fever, weight loss,
splenomegaly, hepatomegaly, or lymphadenomegaly.
Haematology and biochemistry
The following variables were determined using an auto-
mated blood analyser (Sysmex XT-2000i, Roche Diagnos-
tics, Spain): red-blood-cell count (RBCC), reticulocyte
count, haemoglobin concentration, haematocrit, red cell
distribution width (RDW), mean corpuscular volume
(MCV), mean corpuscular haemoglobin (MCH), mean cor-
puscular haemoglobin concentration (MCHC), leukocyte
and platelet count. Differential white blood cell counts were
conducted by conventional microscopy procedures. A clin-
ical biochemical analyser (Cobas integra® 400 plus, Roche
Diagnostics, Spain) was used for serum concentrations of
glucose, total protein, albumin, globulin, urea and creatin-
ine; aspartate aminotransferase (AST) activity, alanine ami-
notransferase (ALT) activity, glutamyltransferase (GGT)
activity, creatinine kinase (CK), alkaline phosphatase (ALP)
activity and total, direct and indirect bilirubin concentra-
tions. All tests were performed using standard techniques.
Platelet numbers and hepatic enzyme activities could not
always be determined due to platelet aggregation or
haemolysis.
Microscopic detection of the parasite
Giemsa-stained thin blood smears were examined by
light microscopy (LM) to detect small intraerythrocyte
ring-shaped bodies compatible with T. annae. The
smears were air dried, fixed in absolute methanol for
5 min, stained using 20% Giemsa and then observed
using a 1000× magnification objective under immersion
oil. All samples were examined by the same technician.
Serum antibodies
Anti-Babesia antibodies were detected by the immuno-
fluorescent antibody test (IFAT) using a commerciallyavailable antigen kit (MegaScreen® FLUO BABESIA
microti, Austria). Fixed erythrocytes infected with Babesia
microti were used as antigen. The IFAT was performed
according to the manufacturer’s instructions using a cut-
off = 1:64 to denote seropositivity. Positive sera were
further tested in a serial dilution series (from1:32). Slides
were examined by the same reader under a fluores-
cence microscope.
Serological testing for the most prevalent CVBD present
in Spain [30], Leishmania infantum and Ehrlichia canis,
was also performed by IFAT.
In the L. infantum test, specific antibodies were de-
tected against in-house cultured promastigotes and anti-
Leishmania-specific immunoglobulin G (IgG) antibodies
were detected as described previously [31] using a cut-
off =1:100 to denote seropositivity. The serial dilutions
prepared were 1/25, 1/50, 1/100, 1/200, 1/400, 1/800
and 1/1600.
IFAT for anti-E. canis antibodies was only performed in
75 dogs in which T. annae was PCR confirmed. For this
test, a local strain was used as antigen and a cut-off =1:80
was taken to denote seropositivity.
DNA isolation and PCR-RFLP
Genomic DNA was isolated from peripheral whole blood
(100 μl) using the QIAamp® DNA blood micro kit (QIA-
GEN®, USA) as described by the manufacturer. The ex-
tracted DNA was eluted in molecular-grade water (70 μl)
and stored at −20°C until further use. DNA quality was
quantified fluorometrically using the Qubit® system (Life
Technologies, USA). Blood-DNA was screened for piro-
plasms using PCR-based assays targeting the small subunit
ribosomal RNA gene (18S rDNA). The implemented
assays included a shorter nested PCR (850 bp; primers BT
F1/R1 followed by BT F2/R2) [28].
PCR products were run on a 1% agarose gel containing
SYBR Safe Gel Stain (Invitrogen, USA), and visualized
with a dark reader trans-illuminator (Clare Chemical,
USA). PCR products corresponding to the expected
length were excised, and sequenced using an ABI Prism
Terminator Cycle Sequencing kit (Applied Biosystems,
USA) in an Applied Biosystem 3730 DNA Analyzer.
Phylogenetic analysis
Phylogenetic analysis was conducted on the sequences
obtained during the present study and additional piro-
plasms sequences available in GenBank.
Sequence chromatogram files were analyzed by
FinchTV 1.4 (http://www.geospiza.com), and imported
into Geneious Pro V. 7.1.5 (Biomatters, Auckland, NZ),
for editing, assembly and alignments. Alignments ob-
tained by MAFFT v7.017 [32] and MUSCLE [33] were
trimmed manually and trees were reconstructed using
the Geneious FastTree plugin [34]. When applicable,
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with the low-stringency set of options selected.
Cardiosporidium cionae was used as an outgroup based
on previous recommendations [37].
Tick collection and identification
Ticks were obtained from dogs observed to have ticks in
the clinical examination and stored in 70% ethanol for
identification to species level, sexing and staging using
morphological keys [38].
Statistical analysis
Results were analysed using the statistics package SAS
version 9.4. IFAT and microscopy results were compared
with molecular results using McNemar’s test, simple
Kappa coefficient and Wilcoxon scores (Rank Sums).
PCR and sequencing was used as the gold standard refer-
ence method to identify small piroplasms [29,39]. Sensitiv-
ity and specificity are provided for each of the techniques
used. Sensitivity was calculated as the number of LM or
IFAT positive results divided by the number of PCR posi-
tive results, and specificity as the number of LM or IFAT
negative results divided by the total number of PCR nega-
tive results. According to the central limit theorem, our
sample was sufficiently large (N > 30) for the use of para-
metric tests. Relationships between T. annae infection and
the remaining categorical variables were assessed using
the Chi-squared test and between T. annae infection and
continuous variables by the Student t-test. Significance
was set at p ≤ 0.05.
Results
Molecular diagnosis
Inclusion criteria for this study were met by 120 dogs. In
75 of these dogs (62.5%), T. annae infection was
confirmed by PCR and sequencing, these animals are
hereafter referred to as “true cases of T. annae infection”.
In 15 of the dogs enrolled, Babesia gibsoni was PCR-
detected in 3 and B. canis in 12.
When we compared our 75 sequencing results with
existing GenBank entries, the sequences obtained were
identified as T. annae in BLAST searches. All the se-
quences obtained were above 98% identical to T. annae.
Several iterative bioinformatics steps were implemented
for careful validation of the input data. Inclusion in the
final subset used for the phylogenetic reconstruction was
based on chromatogram quality, length, specificity and
position of the sequence within the alignment. After a pre-
liminary selection, 43 sequences with lengths ranging
from 231 to 770 bp (Mean: 617.7; Std Dev: 125.4) were
processed further. BLAST-searches returned hits for
canine piroplasms and members of the B. microti group.
After trimming, two un-curated alignments were obtained
and used for the phylogenetic reconstructions (575 bp, 93sequences, 83.9% pairwise identity and 223 bp, 104 se-
quences, 91.8% pairwise identity). In particular, while the
shorter alignment included all the sequences from the
present study, in the longer only the longest sequences
were retained. Regardless of the alignment length and
implementation of the optional curation step (by
Gblocks), all sequences obtained during the present study
clearly grouped with either canine babesias (e.g., B. canis,
B. gibsoni) or within the B. microti group (e.g., T. annae
isolate Dog#8, Acc. No. JX454779).
Microscopy and serology results related to PCR results
The results obtained for the three diagnostic techniques
employed are provided in Figure 1. Intraerythrocytic ring-
shaped bodies, morphologically compatible with small
piroplasms (Figure 2) were detected by LM in 59 of the
120 blood samples (49.2%), two of which were confirmed
as false positives. In one of these false positives, no piro-
plasm DNA was detected by PCR while the other case
was sequenced as B. canis.
Anti-Babesia antibodies were detected by IFAT in 59 of
the 120 dogs (49.2%), four of which were confirmed as
false positives. In two of these, no piroplasm DNA was de-
tected and in the remaining two, the presence of B. canis
was observed. Antibody titres were 1/64 to 1/1024 and
distributed as follows: 1/64 (n = 27), 1/128 (n = 17), 1/256
(n = 4), 1/512 (n = 3), 1/1024 (n = 5), and 1/2048 (n = 3).
We observed good agreement between a positive LM
and PCR result, and between a positive IFAT and PCR
result (Tables 1 and 2). Kappa values indicated moderate
agreement in both cases (0.6680 and 0.6017, respect-
ively) though better agreement was observed between
LM and PCR than between IFAT and PCR. Sensitivities
and specificities were 76% and 95.6% for LM and 77.3%
and 91.1% for IFAT, respectively
When comparing the use of LM plus IFAT versus
PCR, a greater sensitivity was observed (85.33%) than if
we used either technique on its own. However, specifi-
city was reduced (86.66) (Table 3).
A greater number of positive PCR results was detected
in samples testing LM- or IFAT negative, than negative
PCR results in samples testing LM- or IFAT positive. The
McNemar test indicated these were not chance discrepan-
cies meaning that false negatives were more likely than
false positives for LM (p = 0.0003) and IFAT (p = 0.0011)
compared to PCR for a diagnosis of T. annae.
According to the Wilcoxon rank sum test, antibody ti-
tres and PCR results were positively correlated (p = 0.03)
such that high antibody titres were associated with the
presence of parasite DNA in the blood.
Vector-borne diseases serology testing
Anti-L. infantum antibodies were detected by IFAT in
13 of the 120 dogs (10.8%). Nine of these animals (9/13)
Figure 1 Decision tree for the diagnostic approach to dogs with suspected clinical signs and/or clinicopathological abnormalities
consistent with T. annae infection. Abbreviations: IFAT = immunofluorescence antibody test, LM = light microscopy, PCR = polymerase
chain reaction.
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titres were low (1/100 in 5 dogs and 1/200 in 4 dogs). A
further three of these dogs (3/13) tested PCR positive for
other piroplasm species and antibody titres were also
low (1/200 in 2 dogs with B. canis and 1/100 in 1 dog
with B. gibsoni). These animals showed no clinical or
other signs of leishmaniosis (e.g., lymphadenomegaly,
cutaneous lesions, hypergammaglobulinaemia, hypoalbu-
minaemia). In the remaining dog showing anti-L.Figure 2 Intraerythrocytic ring-shaped bodies, morphologically compinfantum antibodies (1/13), T. annae was not detected
and clinical signs were compatible with canine leishma-
niosis. In this animal the antibody titre was 1/400.
Anti-E. canis antibodies were not detected by IFAT in
any of the 75 true infection cases.
Clinical picture
In this section, we describe the clinical picture observed in
the 75 dogs confirmed by PCR to be infected by T. annae.atible with T. annae. Giemsa stained blood smear (x1000).




LM NEGATIVE 43 18 61
POSITIVE 2 57 59
TOTAL 45 75 120
Kappa 0.6680, specificity 95.56%, sensitivity 76%, positive predictive values
(PPV) 96.61%, negative predictive values (NPV) 70.49%.
Table 3 Correlation between IFAT-LM and PCR used to
detect T. annae infection
PCR
Negative Positive Total
LM & IFAT NEGATIVE 39 6 50
POSITIVE 11 64 70
TOTAL 45 75 120
Kappa 0.7043, specificity 86.66%, sensitivity 85.33%, positive predictive values
(PPV) 91.42%, negative predictive values (NPV) 78%.
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apathy (51.4%), loss of appetite (41.6%) and weakness
(19.4%). The most prevalent clinical signs observed in the
physical examination were pale mucous membranes
(69.9%), anorexia (73.9%) and apathy (66.6%). Other
reported clinical signs were orangey faeces (12.5%), vomit-
ing (5.5%), tachycardia (13.8%), fever (29.6%), weight loss
(11.7%), haematuria (18.5%) and splenomegaly (25%).
Significant differences between T.annae-infected and non-
infected dogs were detected in the clinical signs pale
mucous membranes (p = 0.0147), anorexia (p = 0.0374)
and orangey faeces (p= 0.02).
The main haematological finding was regenerative
anaemia in 79.6% (57/72) and non-regenerative anaemia
in 6.9%. Most sick dogs had mild to severe anaemia, 80%
showing less than 4.2 x 106 erythrocytes/ml, 12.2 g
haemoglobin/dl and 33% haematocrit. Anaemia was
most often hypochromic and macrocytic. Median red
blood cell counts, haemoglobin concentrations and hae-
matocrits in infected dogs were clearly lower compared
to reference values or corresponding values for the
group of non-infected dogs. In addition, MCV values
were significantly higher and MCHC values were sig-
nificantly lower in infected compared to non-infected
dogs (Table 4).
The second most frequent haematological abnormality
was thrombocytopenia (58.3%). Leukocyte counts were
elevated in 18 out of 72 infected dogs (mostly with
neutrophilia) and diminished in 5. Eosinopenia was ob-
served in 23 out of 68 infected dogs. The main biochemical
abnormalities detected were hyperglobulinaemia (33/65)
and elevated hepatic enzyme activities (25/57). Azotaemia
was observed in a few cases (7/71) yet differences were




IFAT NEGATIVE 41 20 61
POSITIVE 4 55 59
TOTAL 45 75 120
Kappa 0.6017, specificity 91.11%, sensitivity 73.33%, positive predictive values
(PPV) 93.22%, negative predictive values (NPV) 67.21%.Epidemiological data
Of the 120 dogs included in this study, 103 dogs were
from Galicia, 73 of which tested positive for T. annae
infection, and 17 dogs were from a neighbouring area
(Asturias), two of which tested positive for the parasite
(Figure 3). One of the two PCR-confirmed cases in
Asturias had never left that area.
Epidemiological data compiled for the 75 confirmed T.
annae cases are provided in Table 5. No differences
emerged according to sex or breed. However, a greater
number of positive cases (81.54%) were recorded in
dogs ≤ 3 years (p = 0.0001) compared to older dogs
(46.8%). Significant correlations were also noted between
T. annae infection and a small or medium dog size (≤22
Kg) (p = 0.0012) or being a hunting dog (p = 0.014).
In addition, higher percentages of T. annae positive
dogs were recorded in dogs living in rural (66.6%) than
urban areas (45.8%). There was no significant correlation
between seasonality and T. annae infection. Further,
46.6% (35/75) of T. annae infected dogs were found to
have ticks yet no significance was detected for this risk
factor (data recorded during signalment). We collected 42
ticks from 22 dogs, 15 of which were true infection cases.
These ticks were identified as Ixodes hexagonus (50%),
Ixodes ricinus (19%), Dermacentor reticulatus (16%), and
Dermacentor marginatus (5%). Only, four nymphs could
be classified to the genus level as Ixodes spp.. Ixodes hexa-
gonus was identified in 10 of the 15T. annae infected
dogs.
Discussion
In this study,T. annae infection was assessed by PCR, LM
and IFAT on blood and serum samples obtained from
dogs in NW Spain suspected of having piroplasmosis.
Microscopy examination is the easiest and most
accessible diagnostic test, requiring a well prepared and
suitably stained blood smear together with a trained ob-
server. Our results indicate the good specificity (95.56%)
and moderate sensitivity (76%) of this procedure as well
as its moderate agreement with PCR. However, it should
be noted that we assume that most of the dogs exam-
ined here were in the clinical phase of T. annae infection
when the visual detection of piroplasms is easier than in
animals with low parasitaemia levels due to chronic
Table 4 Descriptive statistics and comparative Student t-test for haematological variables recorded in T. annae
infected (n = 75) and non-infected dogs (n =45)
Blood variable (normality
reference range)
Group N Mean SD Percentiles P value
25th 50th 75th
Erythrocytes (5.50-8.50)x106 /μl I 72* 3.28 1.63 2.16 2.77 4.32 <0.0001
NI 38* 4.9 2.04 3.57 5.3 6.06
Haematocrit (37.00-55.0)% I 72 27.12 11.9 18.6 23.45 36.2 0.0019
NI 38 35.16 13.86 23.50 36.75 44.9
Haemoglobin (12.00-18.00)g/dl I 72 7.75 3.75 5 6.5 10.2 <0.0001
NI 38 11.04 4.57 6.5 12 14.1
MCV (60.00-76.00)fl I 72 82.84 8.25 76 81.5 83.3 0.0088
NI 38 76.02 12.99 70.1 73 75.6
MCHC (32.00-36.00)g/dl I 72 28.25 2.61 26.7 28.2 29.7 <0.0001
NI 38 31.2 3.12 29.5 31.2 32.7
MCH (19.5-24.5)pg I 72 23.18 1.73 22.1 23.1 23.8 0.5552
NI 38 23.59 4.08 22.1 23 23.8
RDW (14.00-20.25)% I 72 17.44 3.26 15.1 17.45 19.2 0.1385
NI 38 16.47 3.06 14.5 14.9 18.5
Leukocytes (6.00-17.00)x103/μ I 72 14.42 6.25 10.5 13.32 17.1 0.3649
NI 38 12.64 11.3 7.89 10.84 14.54
Platelets (200–500) x103/μl I 59 158.5 90.35 90 165 218 0.019
NI 33 211.2 121.25 150 212 272
*no data available for 3 infected and 7 non-infected dogs.
SD: standard deviation.
I = T. annae infected dog; NI = T. annae non-infected dogs.
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sitive to detect chronic and sub-clinical piroplasmosis in
carrier dogs [40].
We considered the molecular approach as the gold stand-
ard method for the diagnosis of small piroplasm infections.
Accordingly, using the molecular diagnostic test, a larger
number of positive dogs for T. annae infection were de-
tected (62.5%). Other PCR assays used to diagnose B. gib-
soni infections have shown a high specificity and sensitivity
[29,41]. In the latter studies, PCR was able to detect the
parasite both at an earlier stage of infection than IFAT or
LM and in the late stages of infection, when parasitaemia
levels are low and Giemsa-stained thin blood smears
return negative results [41]. Nevertheless, false negative
PCR results have been reported in chronic babesiosis,
attributed to parasite elimination from the circulating
blood by the host [40]. This could determine that in the
long term (up until 420 days post-infection) an infection
might only be revealed (retrospectively) by serology [42].
In agreement with a previous report [43], we observed
moderate agreement between our IFAT and PCR results.
In contrast, discrepancies were reported by Kubelová
et al. [44] for these techniques in endemic areas of ca-
nine piroplasmosis.Serological cross-reactions between T. annae and B. canis
were produced in two dogs. Cross reactions have been also
reported between B. gibsoni and B. canis by other authors
[45]. Most of the present dogs testing seropositive for T.
annae (n = 59) showed low antibody titres (1/64 or 1/128).
Such titres reflect an early stage of infection. For B. canis, it
has been described that the first detectable IgG antibodies
usually appear 2–3 weeks after infection [46,47]. In
addition, low antibody titres could be indicative of past in-
fection or exposure and not necessarily of present infection.
A serological diagnosis is therefore a more reliable method
for the detection of hidden or past infections (i.e. chronic-
ally infected carrier dogs) though acute infections may not
be accurately diagnosed if this technique is performed
alone. This issue, however, needs confirmation owing to a
lack of serological data. It has recently been argued that the
diagnosis of infection by a vector-borne pathogen in dogs
can be improved by running serological and PCR based
tests in parallel [48]. However, we observed no benefits of
the use of both techniques over that of PCR alone. Serology
is unable to distinguish between B. canis, T. annae and B.
gibsoni infection, and blood smears cannot distinguish be-
tween T. annae and B. gibsoni. Indeed, the latter technique
is also unable to discriminate B. canis which, though
Figure 3 Results obtained using each diagnostic method by study area.
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morphic intermediate-sized intraerythrocyte stages.
In the current study, PCR and sequencing using univer-
sal primer sets specific for piroplasmida enabled the detec-
tion of a larger number of animals harbouring T. annae,
compared to the other techniques (Figure 1). However,
our study failed to clarify the taxonomy of T. annae such
that more work is needed to resolve this well recognized
systematics conundrum [7].
The possibility of co-infections should also be considered.
In the north of Spain, summers are warm, winters cool and
rainfall is evenly distributed all year round. Accordingly to
that, Rhipicephalus sanguineus and Phlebotomus pernicio-
sus, vectors frequently reported in Spain, are uncommon in
this region and the prevalences of L. infantum and E. canis
are lower than in the rest of Spain. The seroprevalence of L.
infantum recorded in our study (10.8%) was higher than
previously reported for NW Spain (3.7% and 4.1%) [49,50].
This discrepancy could be attributed to the sick population
selected for our study rather than a cross-sectional popula-
tion. An exemption might be the Orense province in NW
Spain, where a prevalence of 35.6% has been observed,
similar to that reported in endemic areas of Spain [50]. Thisprevalence was attributed by the authors to the bioclimatic
characteristics of this geographical area. Moreover, in this
latter region, the presence of the sandfly, P. perniciosus was
also detected. Only one dog from Ourense, which tested
negative for L. infantum, was enrolled in this study. Twelve
of the dogs examined here showed coinfection with piro-
plasms (T. annae, B. canis or B. gibsoni) and L. infantum.
The findings are similar to those in a previous study that
showed high co-infection rate of L. infantum in the Babesia
positive dogs from Portugal [9]. No E. canis antibodies were
detected in our study, coinciding with the low seropreva-
lence (1.4%) reported for this infection in NW Spain [30].
With respect to the clinical picture, the most common
clinical signs observed in the dogs included in our study
were weakness, pale mucous membranes, haemoglobin-
uria, tachycardia, hyperthermia, tachypnea, and hepatos-
plenomegaly. These signs consistent with those reported
previously for T. annae [25] and Babesia spp. infection
[51] were to be expected because many were responsible
for a clinical suspicion of piroplasmosis and were thus
criteria for inclusion in our study. We observed orangey
faeces in 12.5% of the infected dogs, probably due to
high levels of excreted bilirubin.
Table 5 Epidemiological data recorded in 75 dogs
infected with T. annae confirmed by PCR and sequencing
Variable N° total dogs N° positive
T. annae dog (%)
Age (years) ≤3 65 53 (81.54)**
>3 47 22 (46.81)
unknown 8 0
Sex Male 58 38 (65.5)
Female 55 37 (67.2)
unknown 7 0
Size (kg) ≤22 77 59 (76.6)*
>22 35 16 (45.71)
unknown 8 0
Breed Pure breed 86 53 (61.6)
Crossbreed 33 22 (66.6)
unknown 1 0
Lifestyle Hunting 75 56 (74.6)*
Companion 28 13 (46.4)
Guard 12 6 (50)
unknown 5 0
Habitat Rural 96 64 (66.6)
Urban 24 11 (45.8)
Tick infestation Yes 50 35 (70)
No 49 27 (55.1)
unknown 21 13 (10.8)
Seasonality spring 20 14 (70)
summer 20 10 (50)
autumn 60 38 (63.3)
winter 20 13 (65)
**p ≤ 0.0001; *p ≤ 0.02.
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were the main haematological findings observed, consist-
ent with prior reports [13]. Regenerative anaemia was
typically macrocytic/hypochromic with increased num-
bers of reticulocytes observed that were relatively larger
than mature red blood cells. Reticulocytes are hypochro-
mic because they have not completed haemoglobin syn-
thesis. These haematological abnormalities have been
also described by others in T. annae infected dogs in
NW Spain [25].
The red blood cell counts, haematocrits and haemoglobin
levels recorded in the present animals with suspected piro-
plasmosis are in agreement with those reported for 62T.
annae -infected dogs examined in 2003, 90% of which
showed values lower than 4.46 x 106 erythrocytes/μL,
10.52 g haemoglobin/dL and 31.04% haematocrit [13].
Leukocyte abnormalities have been inconsistently observed
in dogs with piroplasmosis [25]. Total leukocyte countswere greater than 17 x103 cells/μL in 25% of the animals
examined here, and there was a trend towards neutrophilia
and eosinopenia. This could be a consequence of the severe
stress associated with this illness, in line with observations
by other authors [13].
We only detected a few cases of azotaemia (9.8%) des-
pite others observing its high prevalence in this disease
(36%) [13,52] and suggesting its strong correlation with
the likelihood of death within the first week of diagnosis
[52]. High ALP activity was observed in 43.8% of the in-
fected dogs despite reports of liver disease only in other
types of piroplasmosis [53].
Our epidemiological results are in agreement with ob-
servations by García et al. [13], who mentioned that the
age distribution of their study population reflected a
greater risk of infection in younger animals [13]. Fre-
quencies of infection by Babesia species in endemic
areas have been described as inversely proportional to
animal age. The correlation observed here, between an
animal weight under 22 kg or a hunting type dog and a
greater likelihood of T. annae infection, could reflect the
fact that hunting dogs are usually fairly light. A large
number of the T. annae infected dogs included in our
study lived in rural areas and were infested by ticks.
Other authors have reported a greater risk of T. annae
infection in hunting dogs or dogs infested by ticks
[25,54]. As also noted for other Babesia species [54,55],
we observed no correlation between T. annae infection
and sex or breed. García et al. [13] reported that autumn
and winter were the periods when most cases of T.
annae were observed. However, we observed no signifi-
cant correlation between season and T. annae infection.
By PCR and sequencing, we detected three positive cases
of B. gibsoni infection among the 120 dogs with suspected
piroplasmosis. However, we have insufficient data to con-
firm the autochthonous nature of these cases. B. gibsoni
has been sporadically reported in dogs travelling to
endemic areas [10,14] and more epidemiological studies are
needed to evaluate its presence in Spain. In contrast, B.
canis has been often identified in dogs in northern Spain
and Portugal [56] and both its diagnosis and clinical man-
agement by veterinarians in these regions are effective [8].
Despite not being included in our study, among dogs diag-
nosed in the participating clinics as having piroplasmosis
caused by B. canis, 12 cases proved PCR positive. This
could reflect the high prevalence of B. canis in NW Spain
and its similar clinical signs to T. annae infection. More-
over, the pleomorphic nature of B. canis hinders its micros-
copy identification and a molecular confirmation is often
required on which to base selection of the best treatment
option. One of the two PCR-confirmed cases in Asturias
(outside Galicia) had never left that area, suggesting that
T. annae infection could be spreading to neighbouring
regions. This idea requires confirmation in future studies.
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Currently, microscopy detection of the parasite is the
most simple and rapid diagnostic method, provided it is
performed by a specialized technician. This procedure
shows a moderate sensitivity for the pathogen in the
acute infection stage when IFAT-determined antibody ti-
tres are low. However, sensitivity increases when IFAT
and LM are used together. PCR is able to detect a larger
number of positive cases and confirm the species in-
volved. For an accurate diagnosis, we would recommend
an integrative approach based on epidemiological evi-
dence, the clinical picture, LM and/or IFAT, and con-
firmation of the infecting species by a molecular
method. We propose that the decision tree in Figure 1
may be useful for clinically managing T. annae infection
in endemic regions or in dogs travelling to an endemic
area. With regards to the possibility that this small piro-
plasm could spread across northern Spain, we fear that
bordering areas of Galicia with similar climate condi-
tions could be already affected. This concern determines
a need for larger epidemiological surveys in which mo-
lecular and serological methods are used to detect dogs
with chronic or subclinical infection. The data emerging
from such studies will serve to more reliably establish
the current prevalence of T. annae infection in northern
mainland Spain. Finally, our study does not clarify the
systematics of T. annae such that we recommend more
work in this area.
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